Affordable Access

E1A as a tumor suppressor gene: commentary re S. Madhusudan et al. A multicenter Phase I gene therapy clinical trial involving intraperitoneal administration of E1A-lipid complex in patients with recurrent epithelial ovarian cancer overexpressing HER-2/neu oncogene.

Authors
  • Frisch, Steven M
Type
Published Article
Journal
Clinical cancer research : an official journal of the American Association for Cancer Research
Publication Date
May 01, 2004
Volume
10
Issue
9
Pages
2905–2907
Identifiers
PMID: 15131023
Source
Medline
License
Unknown
Report this publication

Statistics

Seen <100 times